- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 in immunocompromised individuals
Authors
Keywords
-
Journal
IMMUNITY
Volume 55, Issue 10, Pages 1779-1798
Publisher
Elsevier BV
Online
2022-09-13
DOI
10.1016/j.immuni.2022.09.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series
- (2022) Sophie Caillard et al. ANNALS OF INTERNAL MEDICINE
- Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae
- (2022) Yapeng Su et al. CELL
- Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment
- (2022) Silvia Bellesi et al. LEUKEMIA & LYMPHOMA
- Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
- (2022) Chansavath Phetsouphanh et al. NATURE IMMUNOLOGY
- Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses
- (2022) Victoria G. Hall et al. NATURE IMMUNOLOGY
- Pathological sequelae of long-haul COVID
- (2022) Saurabh Mehandru et al. NATURE IMMUNOLOGY
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homologous and Heterologous Covid-19 Booster Vaccinations
- (2022) Robert L. Atmar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lessons learned from the use of convalescent plasma for the treatment of COVID-19 and specific considerations for immunocompromised patients
- (2022) Mickael Beraud et al. TRANSFUSION AND APHERESIS SCIENCE
- Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
- (2022) Rhia Kundu et al. Nature Communications
- Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021
- (2022) Christina Yek et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
- (2022) Yihao Liu et al. Cell Discovery
- Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
- (2022) Ariel Israel et al. Vaccines
- Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
- (2022) Richard Vollenberg et al. Biomedicines
- CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
- (2022) Akinao Okamoto et al. Blood Advances
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
- (2022) Robert B M Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with CLL have lower risk of death from COVID-19 in the omicron era
- (2022) Carsten Utoft Niemann et al. BLOOD
- Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
- (2022) Robert Stuver et al. CANCER CELL
- Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
- (2022) Maximilian J. Mair et al. CANCER CELL
- Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T-cell responses
- (2022) Olga Lyudovyk et al. CANCER CELL
- COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
- (2022) Daniele Focosi et al. CLINICAL MICROBIOLOGY REVIEWS
- Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
- (2022) Andreas Zollner et al. GASTROENTEROLOGY
- A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
- (2022) Ilies Benotmane et al. KIDNEY INTERNATIONAL
- Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
- (2022) Lennard Y W Lee et al. LANCET ONCOLOGY
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
- (2022) Timothée Bruel et al. NATURE MEDICINE
- SARS-CoV-2 pathogenesis
- (2022) Mart M. Lamers et al. NATURE REVIEWS MICROBIOLOGY
- Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
- (2022) Rebecca Rockett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
- (2022) Myron J. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
- (2022) Ori Magen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
- (2022) Gili Regev-Yochay et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of COVID-19 vaccination in melanoma patients under immune checkpoint blockade
- (2022) Jacqueline Niewolik et al. ONCOLOGY
- Persistent COVID-19 symptoms in a community study of 606,434 people in England
- (2022) Matthew Whitaker et al. Nature Communications
- Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
- (2022) Fanglei Zuo et al. Nature Communications
- Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
- (2022) Vanessa Piechotta et al. Blood Cancer Journal
- The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
- (2022) Jean-Eudes Fahrner et al. Cancer Discovery
- Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
- (2022) Edward P K Parker et al. Lancet Global Health
- Use of At-Home COVID-19 Tests — United States, August 23, 2021–March 12, 2022
- (2022) Benjamin Rader et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021
- (2022) William Wang et al. JAMA Oncology
- Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
- (2022) Michel Obeid et al. JAMA Oncology
- Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
- (2022) Takuya Tada et al. EBioMedicine
- Understanding T cell responses to COVID-19 is essential for informing public health strategies
- (2022) Santosha Vardhana et al. Science Immunology
- Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study
- (2022) Sean W. X. Ong et al. Antibiotics-Basel
- Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
- (2022) Grégory Destras et al. Lancet Microbe
- Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
- (2022) Ameena Goga et al. LANCET
- PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
- (2022) Ramin Sedaghat Herati et al. NATURE IMMUNOLOGY
- Symptoms and risk factors for long COVID in non-hospitalized adults
- (2022) Anuradhaa Subramanian et al. NATURE MEDICINE
- Risk of severe COVID-19 infection among adults with prior exposure to children
- (2022) Matthew D. Solomon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records
- (2022) Ellen J. Thompson et al. Nature Communications
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Higher SARS-CoV-2 Infection Rate in Pregnant Patients
- (2021) Erica M. LOKKEN et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
- (2021) Markus Cornberg et al. JOURNAL OF HEPATOLOGY
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
- (2021) Kevin R. McCarthy et al. SCIENCE
- SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
- (2021) Line K. Vibholm et al. EBioMedicine
- Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy
- (2021) Rémy Duléry et al. AMERICAN JOURNAL OF HEMATOLOGY
- Covid‐19 in hospitalized lung and non‐lung solid organ transplant recipients: a comparative analysis from a multicenter study
- (2021) Madeleine R. Heldman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose
- (2021) Evangelos Terpos et al. BLOOD
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- A molecular single-cell lung atlas of lethal COVID-19
- (2021) Johannes C. Melms et al. NATURE
- COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
- (2021) Toni M. Delorey et al. NATURE
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
- (2021) Tom T. Shimabukuro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
- (2021) Stefania Dispinseri et al. Nature Communications
- The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient – a case study
- (2021) Chiara Sepulcri et al. Open Forum Infectious Diseases
- Prolonged SARS CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
- (2021) Elena G Gibson et al. Open Forum Infectious Diseases
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient
- (2021) Lawrence J. Purpura et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
- (2021) Paola Ghione et al. BLOOD
- Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
- (2021) Raffaella Greco et al. BONE MARROW TRANSPLANTATION
- Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
- (2021) Patrick Harrington et al. BRITISH JOURNAL OF HAEMATOLOGY
- Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
- (2021) Oliver Van Oekelen et al. CANCER CELL
- Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
- (2021) Etheresia Pretorius et al. Cardiovascular Diabetology
- Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study
- (2021) Jessica Seeßle et al. CLINICAL INFECTIOUS DISEASES
- Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies
- (2021) Jorge Calderón-Parra et al. CLINICAL INFECTIOUS DISEASES
- Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience
- (2021) John Paul Verderese et al. CLINICAL INFECTIOUS DISEASES
- Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
- (2021) Mark M. Painter et al. IMMUNITY
- Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
- (2021) Aodhán Seán Breathnach et al. JOURNAL OF INFECTION
- Cycle threshold values in RT‐PCR to determine dynamics of SARS‐CoV‐2 viral load: An approach to reduce the isolation period for COVID‐19 patients
- (2021) Clara Aranha et al. JOURNAL OF MEDICAL VIROLOGY
- Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients
- (2021) Hagai Ligumsky et al. JNCI-Journal of the National Cancer Institute
- COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
- (2021) Per Ljungman et al. LEUKEMIA
- CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
- (2021) Erin M. Bange et al. NATURE MEDICINE
- Molnupiravir: coding for catastrophe
- (2021) Brandon Malone et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
- (2021) Meagan P. O’Brien et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants in Patients with Immunosuppression
- (2021) Lawrence Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know
- (2021) Maddalena Giannella et al. TRANSPLANT INTERNATIONAL
- Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series
- (2021) Sherif M Shoucri et al. BMJ Open
- Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma
- (2021) Vítor Borges et al. mSphere
- Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
- (2021) Abed Agbarya et al. Cancers
- Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
- (2021) Samuele Notarbartolo et al. Science Immunology
- Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
- (2021) Benjamin Israelow et al. Science Immunology
- Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
- (2021) Hector Rincon-Arevalo et al. Science Immunology
- Different Within-Host Viral Evolution Dynamics in Severely Immunosuppressed Cases with Persistent SARS-CoV-2
- (2021) Laura Pérez-Lago et al. Biomedicines
- Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
- (2021) C. Perry et al. Blood Advances
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
- (2021) Nora Liebers et al. BLOOD
- Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
- (2021) Patrick Reimann et al. BRITISH JOURNAL OF HAEMATOLOGY
- T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
- (2021) Vincenzo Marasco et al. BRITISH JOURNAL OF HAEMATOLOGY
- Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
- (2021) Patrick Harrington et al. CANCER CELL
- Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
- (2021) Annika Fendler et al. CANCER CELL
- Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
- (2021) Andrea Becerril-Gaitan et al. EUROPEAN JOURNAL OF CANCER
- Successful Treatment of Persistent SARS-CoV-2 Infection in a B-Cell Depleted Patient with Activated Cytotoxic T and NK Cells: A Case Report
- (2021) Jacek Jassem et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of chronic or relapsing COVID-19 in immunodeficiency
- (2021) Li-An K. Brown et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
- (2021) Vivek Naranbhai et al. JOURNAL OF CLINICAL ONCOLOGY
- Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2021) Michael J Peluso et al. JOURNAL OF INFECTIOUS DISEASES
- B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
- (2021) Eva Schrezenmeier et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
- (2021) Sjoukje F Oosting et al. LANCET ONCOLOGY
- A humanized mouse model of chronic COVID-19
- (2021) Esen Sefik et al. NATURE BIOTECHNOLOGY
- Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
- (2021) Rachna T. Shroff et al. NATURE MEDICINE
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women
- (2021) Caroline Atyeo et al. Science Translational Medicine
- Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses
- (2021) Evan A. Bordt et al. Science Translational Medicine
- Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies
- (2021) Christina Y. Lee et al. Cancer Discovery
- Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19
- (2021) Maxime Taquet et al. PLOS MEDICINE
- Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
- (2021) Peter J. Embi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer
- (2021) Julie Tsu-Yu Wu et al. JAMA Oncology
- Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study
- (2021) Carla S Walti et al. Journal for ImmunoTherapy of Cancer
- SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
- (2021) Joshua M. Carmen et al. npj Vaccines
- Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
- (2021) A. Lasagna et al. ESMO Open
- Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
- (2021) Nassim Kamar et al. JAMA Network Open
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
- (2021) Zara Izadi et al. JAMA Network Open
- Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
- (2021) Moraima Jiménez et al. Blood Advances
- Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative
- (2021) Kathleen M Andersen et al. Lancet Rheumatology
- Human genetics of life-threatening influenza pneumonitis
- (2020) Qian Zhang HUMAN GENETICS
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- High IL‐6/IFN‐γ ratio could be associated with severe disease in COVID‐19 patients
- (2020) Francisco Alejandro Lagunas‐Rangel et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Covid-19 and Kidney Transplantation
- (2020) Enver Akalin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Thrombocytopenic Purpura in a Patient with Covid-19
- (2020) Abrar-Ahmad Zulfiqar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
- (2020) Louise Bowles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
- (2020) Annarosa Soresina et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- COVID-19 in Children With Cancer in New York City
- (2020) Farid Boulad et al. JAMA Oncology
- Covid‐19‐associated encephalopathy and cytokine‐mediated neuroinflammation
- (2020) Lorenzo Muccioli et al. ANNALS OF NEUROLOGY
- COVID-19 in patients with lung cancer
- (2020) J. Luo et al. ANNALS OF ONCOLOGY
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
- (2020) Phil‐Robin Tepasse et al. BRITISH JOURNAL OF HAEMATOLOGY
- The Right Time for Steroids in COVID-19
- (2020) Ana Fernández-Cruz et al. CLINICAL INFECTIOUS DISEASES
- COVID ‐19, ketoacidosis, and new‐onset Diabetes: might we envisage any cause‐effect relationships among them?
- (2020) Sandro Gentile et al. DIABETES OBESITY & METABOLISM
- Presence of Genetic Variants Among Young Men With Severe COVID-19
- (2020) Caspar I. van der Made et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19: pharmacology and kinetics of viral clearance
- (2020) Nicola Farina et al. PHARMACOLOGICAL RESEARCH
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- Covid-19: What do we know about “long covid”?
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection
- (2020) Yonatan Peleg et al. Kidney International Reports
- Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease
- (2020) Thomas Hueso et al. BLOOD
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract
- (2020) Fengyu Hu et al. Cellular & Molecular Immunology
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chemotherapy and COVID-19 Outcomes in Patients With Cancer
- (2020) Justin Jee et al. JOURNAL OF CLINICAL ONCOLOGY
- Prolonged SARS-CoV-2 replication in an immunocompromised patient
- (2020) Ji Hoon Baang et al. JOURNAL OF INFECTIOUS DISEASES
- Long-term consequences of COVID-19: research needs
- (2020) Dana Yelin et al. LANCET INFECTIOUS DISEASES
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
- (2020) Matthew C. Woodruff et al. NATURE IMMUNOLOGY
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Long covid could be four different syndromes, review suggests
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
- (2020) ANNALS OF THE RHEUMATIC DISEASES
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
- (2020) Victoria A. Avanzato et al. CELL
- Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
- (2020) Gunjan L. Shah et al. JOURNAL OF CLINICAL INVESTIGATION
- Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
- (2020) Enrico Brunetta et al. NATURE IMMUNOLOGY
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
- (2020) Teresa Aydillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
- (2020) Ruth Fernandez-Ruiz et al. Translational Research
- Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
- (2020) Imad M. Tleyjeh et al. CLINICAL MICROBIOLOGY AND INFECTION
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency
- (2018) Nicholas Hernandez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pathogen infection and autoimmune disease
- (2018) U. Christen CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Community acquired respiratory virus infections in cancer patients—Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
- (2016) Marie von Lilienfeld-Toal et al. EUROPEAN JOURNAL OF CANCER
- Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients
- (2016) Jae-Hoon Ko et al. JOURNAL OF INFECTION
- Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
- (2016) Chan-Ki Min et al. Scientific Reports
- Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
- (2015) M. J. Ciancanelli et al. SCIENCE
- Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
- (2014) D. P. Shah et al. BLOOD
- Effect of rituximab on human in vivo antibody immune responses
- (2011) Mark D. Pescovitz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
- (2010) Michel J. van Vliet et al. PLoS Pathogens
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in Mexico
- (2009) Rogelio Perez-Padilla et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
- (2009) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now